bioRxiv Science⌕ Search

Biology subjects

Konak, D.

Publications and source records attributed to Konak, D..

2 recordsLinked to original sources

A transcriptional continuum from clinically normal to lesional skin: Single-cell trajectory analysis of psoriasis

Psoriasis is a chronic inflammatory skin disease characterized by immune dysregulation and complex cellular interactions involving keratinocytes (KCs), T cells, and endothelial cells. Single-cell studies have mapped the cellular diversity of psoriatic plaques, yet most analyses treat skin as either healthy or diseased and therefore overlook the graded changes that precede a visible lesion. We asked whether psoriasis instead progresses along a transcriptional continuum and whether clinically normal skin from patients already carries a measurable disease signature. Using single-cell RNA sequencing (scRNA-seq) of healthy skin (NS), clinically normal skin adjacent to lesions (PN), and lesional skin (PP), we combined two complementary designs: a complete set spanning all three states and a within-patient paired set of matched PN and PP skin biopsies that removes inter-individual variability. Trajectory analysis using a novel pseudotime approach reveals transcriptional changes within cell populations and dynamic cellular states underlying psoriatic pathology. To distinguish lesion-driven effects from disease-associated transcriptional changes, we applied a differential expression strategy comparing PP and PN psoriatic tissue with NS and integrating these contrasts. This approach enabled the identification of disease-specific gene signatures while minimizing lesion-specific bias. As a result, we identified a coherent, cell-type-resolved continuum of transcriptional states in which endothelial cells, IL20+ keratinocytes (KCs: IL20), and KGF+ keratinocytes (KCs: KGF) undergo trajectory-dependent state transitions. These trajectories converge on features including epidermal thickening, barrier dysfunction, and plaque maintenance. Endothelial cells transition from an inflamed, angiogenic state to a mature, barrier-stabilized phenotype, while KCs: IL20 and KCs: KGF shift from PN states toward hyperproliferative, stress-adapted lesional phenotypes. These findings reframe psoriasis as a dynamic, multicellular continuum and identify candidate temporal windows for early intervention.

bioinformatics↗

Basophilic Erythroblast Emerges as the Key Turning Point in Polycythemia Vera

Abstract Polycythemia vera (PV) is a rare, chronic myeloproliferative neoplasm driven by the JAK2V617F mutation and characterized by uncontrolled erythroid proliferation. Although the mutation arises in hematopoietic stem cells, the differentiation stage at which its transcriptional consequences first become biologically meaningful has remained undefined. Using a multi-layer transcriptomics integration approach that combined differential gene expression, NicheNet ligand-receptor analysis, pseudotime trajectory inference, and CNV profiling on scRNA seq data, alongside bulk transcriptome validation, we identified basophilic erythroblasts as the critical transition point at which JAK2V617F shifts from a genomically present but transcriptionally silent state to an actively trajectory-altering and treatment-responsive disease driver. Differential expression revealed a qualitatively distinct disease signature at this stage, including ERFE-mediated iron dysregulation, MAP2K2-driven RAS/MAPK co-activation, and epigenetic reprogramming. NicheNet showed the establishment of a TGF{beta} superfamily and chemokine-driven niche-remodeling axis, and pseudotime analysis demonstrated that basophilic erythroblasts are the first erythroid population to exhibit condition-dependent trajectory divergence, whereas earlier progenitors showed none despite carrying the mutation. Interferon- treatment showed its broadest counterresponse at this stage but declined sharply thereafter, identifying basophilic erythroblasts as both the principal therapeutic target and the point of maximum vulnerability in PV.

bioinformatics↗